又见基金经理道歉，“有些难熬”

Core Viewpoint - The A-share market has shown signs of recovery this year, leading to improved performance for many actively managed equity funds, although some funds have lagged due to structural market conditions, prompting fund managers to express apologies in their semi-annual reports [1][2]. Fund Performance and Apologies - Fund types expressing apologies include underperforming pharmaceutical funds, dividend funds, and growth funds, indicating a need for fund managers to reassess their investment frameworks and for investors to discern between short-term market style mismatches and long-term managerial capabilities [2][5]. - A pharmaceutical fund manager acknowledged underperformance relative to industry indices and expressed regret for not achieving absolute returns, attributing the poor performance to premature shifts in investment strategy and missed opportunities in the "new drug + new consumption" sector [4][5]. - A dividend fund manager reported negative returns in the first half of 2025, citing both objective market conditions and subjective misjudgments as reasons for underperformance, particularly in avoiding high-recognition sectors while focusing on low-recognition ones [7][8]. Market Trends and Future Outlook - The pharmaceutical sector has seen significant activity, particularly in innovative drug companies, with some funds achieving substantial gains, while others have struggled due to conservative positioning [4][5]. - Fund managers are optimistic about future performance, highlighting potential in low-positioned sectors within the pharmaceutical industry, such as AI healthcare and medical devices, and committing to a more proactive investment approach [5][10]. - Some fund managers reflected on missed opportunities due to early profit-taking and emphasized the importance of maintaining a long-term investment perspective despite short-term challenges [10][11]. Performance Data - Data from Wind indicates that several funds that apologized for their performance have rebounded in the second half of the year, with some achieving net value growth rates of 20% to 30%, significantly outperforming their benchmarks [14][15]. - Specific fund performance metrics show that a dividend mixed fund had a net value growth rate of -3.31% in the first half but rebounded to 11.40% in the second half, while other funds also demonstrated similar recovery trends [14].